Johanna Päivikki Laakkonen

Johanna Päivikki Laakkonen

Auto-generated profile, based on publicly available information

Johanna Päivikki Laakkonen

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2017 in Science Signaling
Verified
Journal Article
Closed access
PDF file
TATomohiro Aoki
Tomohiro Aoki
JFJuhana Frȍsen
Juhana Frȍsen
MFMiyuki Fukuda
Miyuki Fukuda
KBKana Bando
Kana Bando
GSGo Shioi
Go Shioi
SNShuh Narumiya
Shuh Narumiya
Inhibition of prostaglandin E 2 signaling in macrophages may be a pharmacological option for treating intracranial aneurysms.

6 October 2020 in Angiogenesis
Verified
Journal Article
Open access
PDF file
HPH. H. Pulkkinen
H. H. Pulkkinen
MKM. Kiema
M. Kiema
JLJ. P. Lappalainen
J. P. Lappalainen
ATA. Toropainen
A. Toropainen
MBM. Beter
M. Beter
JLJohanna P. Laakkonen
Johanna P. Laakkonen
The BMP/TGFβ-Smad, Notch and VEGF signaling guides formation of endothelial tip and stalk cells. However, the crosstalk of bone morphogenetic proteins (BMPs) and vascular endothelial growth factor receptor 2 (VEGFR2) signaling has remained largely unknown. We demonstrate that BMP family members regulate VEGFR2 and Notch signaling, and act via TAZ-Hippo signaling pathway. BMPs were found to be regulated after VEGF gene transfer in C57/Bl6 mice and in a porcine myocardial ischemia model. BMPs 2/4/6 were identified as endothelium-specific targets of VEGF. BMP2 modulated VEGF-mediated endothelial sprouting via Delta like Canonical Notch Ligand 4 (DLL4). BMP6 modulated VEGF signaling by regulating VEGFR2 expression and acted via Hippo signaling effector TAZ, known to regulate cell survival/proliferation, and to be dysregulated in cancer. In a matrigel plug assay in nude mice BMP6 was further demonstrated to induce angiogenesis. BMP6 is the first member of BMP family found to directly regulate both Hippo signaling and neovessel formation. It may thus serve as a target in pro/anti-angiogenic therapies.

14 April 2023 in The American Journal of Human Genetics
Verified
Journal Article
Open access
TÖTiit Örd
Tiit Örd
TLTapio Lönnberg
Tapio Lönnberg
VNValtteri Nurminen
Valtteri Nurminen
ARAarthi Ravindran
Aarthi Ravindran
HNHenri Niskanen
Henri Niskanen
MKMinna U Kaikkonen
Minna U Kaikkonen
Coronary artery disease (CAD) is a pandemic disease where up to half of the risk is explained by genetic factors. Advanced insights into the genetic basis of CAD require deeper understanding of the contributions of different cell types, molecular pathways, and genes to disease heritability. Here, we investigate the biological diversity of atherosclerosis-associated cell states and interrogate their contribution to the genetic risk of CAD by using single-cell and bulk RNA sequencing (RNA-seq) of mouse and human lesions. We identified 12 disease-associated cell states that we characterized further by gene set functional profiling, ligand-receptor prediction, and transcription factor inference. Importantly, Vcam1+ smooth muscle cell state genes contributed most to SNP-based heritability of CAD. In line with this, genetic variants near smooth muscle cell state genes and regulatory elements explained the largest fraction of CAD-risk variance between individuals. Using this information for variant prioritization, we derived a hybrid polygenic risk score (PRS) that demonstrated improved performance over a classical PRS. Our results provide insights into the biological mechanisms associated with CAD risk, which could make a promising contribution to precision medicine and tailored therapeutic interventions in the future.

12 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TVTaina Vuorio
Taina Vuorio
EYElias Ylä-Herttuala
Elias Ylä-Herttuala
JLJohanna P. Laakkonen
Johanna P. Laakkonen
SLSvetlana Laidinen
Svetlana Laidinen
TLTimo Liimatainen
Timo Liimatainen
Seppo Ylä-HerttualaSeppo Ylä-Herttuala
Seppo Ylä-Herttuala
Heart has a wide lymphatic network but the importance of cardiac lymphatic system in heart diseases has remained unclear. Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) is a key molecule in the development and maintenance of cardiac lymphatic vessels. Here we characterized the role of VEGFR3 in healthy hearts and after myocardial infarction (MI) by using sVEGFR3 transgenic mice expressing a soluble decoy VEGFR3 under K14 promoter and Chy mice which have an inactivating mutation in the VEGFR3 gene. Cardiac lymphatic vessels were significantly dilated in the healthy hearts of sVEGFR3 mice when compared to controls. Lymphatic vessels formed large sheet-like structures in Chy mice. Attenuated VEGFR3 signaling led to a more severe MI predisposing to a significantly higher mortality in sVEGFR3 mice than in control mice. sVEGFR3 mice displayed intramyocardial hemorrhages in the infarcted area indicating hyperpermeability of the vasculature. Furthermore, novel MRI methods TRAFF2 and TRAFF4 and histological analysis revealed a modified structure of the fibrotic infarcted area in sVEGFR3 mice. In conclusion, the downregulation of VEGFR3 signaling modifies the structure of cardiac lymphatic network and causes vascular leakiness and increased mortality after MI.

7 April 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJohanna P. Laakkonen
Johanna P. Laakkonen
AMAnna R. Mäkelä
Anna R. Mäkelä
EKElina Kakkonen
Elina Kakkonen
PTPaula Turkki
Paula Turkki
SKSari Kukkonen
Sari Kukkonen
VMVarpu Marjomäki
Varpu Marjomäki
The prototype baculovirus, Autographa californica multiple nucleopolyhedrovirus, an insect pathogen, holds great potential as a gene therapy vector. To develop transductional targeting and gene delivery by baculovirus, we focused on characterizing the nature and regulation of its uptake in human cancer cells. Baculovirus entered the cells along fluid-phase markers from the raft areas into smooth-surfaced vesicles devoid of clathrin. Notably, regulators associated with macropinocytosis, namely EIPA, Pak1, Rab34, and Rac1, had no significant effect on viral transduction, and the virus did not induce fluid-phase uptake. The internalization and nuclear uptake was, however, affected by mutants of RhoA, and of Arf6, a regulator of clathrin-independent entry. Furthermore, the entry of baculovirus induced ruffle formation and triggered the uptake of fluorescent E. coli bioparticles. To conclude, baculovirus enters human cells via a clathrin-independent pathway, which is able to trigger bacterial uptake. This study increases our understanding of virus entry strategies and gives new insight into baculovirus-mediated gene delivery in human cells.

21 November 2016 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
JLJohanna P. Laakkonen
Johanna P. Laakkonen
JLJari P. Lappalainen
Jari P. Lappalainen
TTThomas L. Theelen
Thomas L. Theelen
PTPyry I. Toivanen
Pyry I. Toivanen
TNTiina Nieminen
Tiina Nieminen
Seppo Ylä-HerttualaSeppo Ylä-Herttuala
Seppo Ylä-Herttuala